These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1069 related items for PubMed ID: 15246197

  • 1. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1037-44. PubMed ID: 16024178
    [Abstract] [Full Text] [Related]

  • 3. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
    Gagel B, Piroth M, Pinkawa M, Reinartz P, Krohn T, Kaiser HJ, Stanzel S, Breuer C, Asadpour B, Schmachtenberg A, Eble MJ.
    BMC Cancer; 2007 Jun 28; 7():112. PubMed ID: 17598906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ, Hanlon AL, Langer C, Goldberg M, Nicolaou N, Millenson M, Coia LR, Lanciano R, Movsas B.
    J Thorac Oncol; 2007 Apr 28; 2(4):287-92. PubMed ID: 17409799
    [Abstract] [Full Text] [Related]

  • 6. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L.
    J Thorac Oncol; 2007 Oct 28; 2(10):927-32. PubMed ID: 17909355
    [Abstract] [Full Text] [Related]

  • 7. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM.
    J Thorac Oncol; 2008 Jan 28; 3(1):59-67. PubMed ID: 18166842
    [Abstract] [Full Text] [Related]

  • 8. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
    Choy H, Jain AK, Moughan J, Curran W, Whipple G, Demas WF, Ettinger DS.
    J Thorac Oncol; 2009 Jan 28; 4(1):80-6. PubMed ID: 19096311
    [Abstract] [Full Text] [Related]

  • 9. Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.
    Lin Q, Liu YE, Ren XC, Wang N, Chen XJ, Wang DY, Zong J, Peng Y, Guo ZJ, Hu J.
    Radiat Oncol; 2013 Aug 17; 8(1):201. PubMed ID: 23957889
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).
    Favaretto A, Ceresoli GL, Paccagnella A, Barbieri F, Bearz A, Ghiotto C, Oniga F, Schiavon S, Frustaci S, Villa E.
    Ann Oncol; 2000 Nov 17; 11(11):1421-6. PubMed ID: 11142482
    [Abstract] [Full Text] [Related]

  • 11. Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.
    Saito H, Nakagawa K, Takeda K, Iwamoto Y, Ando M, Maeda M, Katakami N, Nakano T, Kurata T, Fukuoka M.
    Am J Clin Oncol; 2012 Feb 17; 35(1):58-63. PubMed ID: 21293243
    [Abstract] [Full Text] [Related]

  • 12. Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.
    Divers SG, Spencer SA, Carey D, Busby EM, Hyatt MD, Robert F.
    J Clin Oncol; 2005 Sep 20; 23(27):6664-73. PubMed ID: 16170174
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer.
    Zhang J, Gay HA, Russo S, Parent T, Aljumaily R, Walker PR.
    Lung Cancer; 2014 Jan 20; 83(1):67-72. PubMed ID: 24246506
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B, Piroth M, Pinkawa M, Reinartz P, Zimny M, Fischedik K, Stanzel S, Breuer C, Skobel E, Asadpour B, Schmachtenberg A, Buell U, Eble MJ.
    Strahlenther Onkol; 2006 May 20; 182(5):263-9. PubMed ID: 16673059
    [Abstract] [Full Text] [Related]

  • 15. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D, Neyns B, Fontaine C, Steene JV, De Mey J, Meysman M, De Grève J.
    Lung Cancer; 2007 May 20; 56(2):247-54. PubMed ID: 17337086
    [Abstract] [Full Text] [Related]

  • 16. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
    Vokes EE, Herndon JE, Crawford J, Leopold KA, Perry MC, Miller AA, Green MR.
    J Clin Oncol; 2002 Oct 15; 20(20):4191-8. PubMed ID: 12377962
    [Abstract] [Full Text] [Related]

  • 17. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 18. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.
    Dingemans AM, Bootsma G, van Baardwijk A, Reymen B, Wanders R, Brans B, Das M, Hochstenbag M, van Belle A, Houben R, Lambin P, de Ruysscher D.
    J Thorac Oncol; 2014 May 15; 9(5):710-6. PubMed ID: 24722157
    [Abstract] [Full Text] [Related]

  • 19. Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
    Pallis AG, Syrigos K, Kotsakis A, Karachaliou N, Polyzos A, Chandrinos V, Varthalitis I, Christophyllakis C, Ardavanis A, Vamvakas L, Vardakis N, Saridaki Z, Samonis G, Giassas S, Georgoulias V, Agelaki S.
    Clin Lung Cancer; 2011 Mar 15; 12(2):100-5. PubMed ID: 21550556
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K.
    Ann Oncol; 1999 Sep 15; 10(9):1059-63. PubMed ID: 10572603
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.